Global genetic testing market forecast 2017 2024

GENETIC TESTING MARKET FORECAST 2017-2024 www.InkwoodResearch.com www.InkwoodResearch.com

Report Description • The global genetic testing market is Predicted to grow from $4614 million in 2016 to $9806 million by 2024, at a CAGR of 9.93 % between 2016 and 2024.

• The base year for the study is 2016 and the expected period is between 2017 and 2024.

• Genetic testing is one of the most rapidly growing segments in molecular diagnostics industry that helps in delivering customized health services and is also called as personalized medicine.

Objectives of the study • According to the genetic testing market country outlook, currently, North America holds a dominant market share of in the global market. • This growth of the North American genetic testing market is majorly due to the presence of major players in the market, higher disposable income, good health care infrastructure and increasing awareness about latest technologies. • Asia Pacific genetic testing market is projected to report high growth rate during the forecast years. Good growth is expected due to favorable government policies which are spending more on Commercialization and R&D of the technologically advanced products and the existence of larger target population due to more cases of chronic diseases.

Market Share

Report Insights • The report provides detailed insights into the market, which is segmented by type, application, and region.

• The report includes all the major features of the gene testing market and provides an in-depth analysis over north america, europe, the asia-pacific region (apac), the middle east and africa (mea), and latin america.

• The major players for the genetic testing market are MOLECULARMD corp (US), DAAN Diagnostics Ltd. (Canada), GENENTECH, inc(US), inc.(US), ILLUMINA, Inc.(US), INTEGRAGEN S.A(France), GENOMICTREE, Inc.(South Korea), Myriad Genetics Inc.(US), Natera, Inc (US), Oxford Biodynamic Limited (UK), Pacific Biosciences Of California, Inc.(US), HTG molecular diagnostics, Perkinelmer Inc. (US), CEPHEID (US), QIAGEN N.V.(Netherland), LUMINEX corporation (US), Laboratory Corporation Of America Holdings (US), Roche Diagnostics Corporation(US). Illumina inc. (US) is the major players in the market.

Report Segmentation • MARKET SEGMENTATION • BY TYPE • GLOBAL PREDISPOSITION TESTING MARKET • GLOBAL DIAGNOSTIC TESTING MARKET 2017-2024 ($MILLION) • GLOBAL NEWBORN SCREENING MARKET • GLOBAL PRENATAL TESTING MARKET

• BY APPLICATION • GLOBAL CANCER GENETIC TESTING MARKET • GLOBAL PRENATAL GENETIC TESTING MARKET • GLOBAL PHARMACOGENOMICS MARKET • GLOBAL PREDISPOSITION MARKET

• KEY DATA ANALYTICS

• GEOGRAPHIC ANALYSIS • NORTH AMERICA GLOBAL GENETIC TESTING MARKET 20172024 ($ MILLION) • MARKET DETERMINANT ANALYSIS • PREVALENCE OF CHRONIC DISORDERS ACROSS REGIONAL COUNTRIES • REGIONAL ANALYSIS

• EUROPE GLOBAL GENETIC TESTING MARKET 2017-2024 ($ MILLION) • MARKET DETERMINANT ANALYSIS • REGIONAL ANALYSIS

• ASIA-PACIFIC GLOBAL GENETIC TESTING MARKET • REGIONAL ANALYSIS

• REST OF THE WORLD GENETIC TESTING MARKET • REGIONAL ANALYSIS

Request a Free SampleÂ

To Request A Free Sample Copy Of This Report, Please Click The Link Below https://www.inkwoodresearch.com/reports/global-genetictesting-market-forecast-2017-2024

About Inkwood Research Inkwood Research specializes in syndicated research reports, customized research reports and consulting services. We offer market intelligence studies across a range of industries including Technology, Chemicals, Materials, Healthcare and Energy. With 20 years of research experience, we ensure you efficient deliverables with global and country industry knowledge and research expertise.

Our analysis covers North & South America, Europe, CEE, CIS, Middle East, Africa and Asia. www.InkwoodResearch.com